The Mw vaccine, normally used to treat leprosy patients, was originally developed as an immunomodulator for leprosy.
from Latest News https://www.dnaindia.com/india/report-clinical-trials-of-mycobacterium-w-vaccine-as-an-adjunct-to-covid-19-treatment-will-begin-soon-pgmer-chandigarh-2822678
Sunday, April 26, 2020
Home »
Latest News
,
News
» Clinical trials of Mycobacterium w vaccine as an adjunct to COVID-19 treatment will begin soon: PGMER Chandigarh
0 comments:
Post a Comment